EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States

IndustryMedical Devices
Full Time Employees12,200

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael A. MussallemChairman & CEO3.38M48.81M1953
Mr. Scott B. UllemCorp. VP & CFO1.32MN/A1967
Mr. Donald E. Bobo Jr.Corp. VP of Strategy & Corp. Devel.1.27M4.56M1962
Mr. Larry L. WoodCorp. VP of Transcatheter Heart Valve1.36M5.46M1966
Ms. Catherine M. SzymanCorp. VP of Critical Care1.36MN/A1967
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and related delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings and the beating-heart mitral repair systems; and cardiac cannula devices, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; pulmonary artery catheters; Oximetry Central Venous catheters, as well as clinical monitoring platforms that display a patient's physiological status; and disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

Corporate Governance

Edwards Lifesciences Corporation’s ISS Governance QualityScore as of October 1, 2018 is 2. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 2; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.